Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

86
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
86
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies.

Autoimmunity reviews·2026
Same author

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.

Journal of neurology·2026
Same author

Role of Tocilizumab in Severe CNS Inflammatory Presentations in Children.

Neurology·2026
Same author

Chronic Active Lesions in Pediatric Multiple Sclerosis-Reply.

JAMA neurology·2026
Same author

Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy.

Neurology(R) neuroimmunology & neuroinflammation·2025

Related Experiment Video

Updated: Oct 16, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K

Similarities and differences between multiple sclerosis and type 1 diabetes.

Valeria Pozzilli1,2, Eleonora Agata Grasso1,2,3, Valentina Tomassini1,2

  • 1Department of Neurosciences, Imaging and Clinical Sciences, Institute of Advanced Biomedical Technologies (ITAB), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.

Diabetes/Metabolism Research and Reviews
|October 15, 2021
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) and type 1 diabetes (T1D) are autoimmune diseases with shared genetic and environmental factors. While both involve T-cells, MS is treated with immunomodulation and T1D with hormone replacement, reflecting different typical age onsets.

Keywords:
COVID-19SARS-CoV-2 infectionautoimmunitycomorbiditymultiple sclerosistype 1 diabetes

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

Related Experiment Videos

Last Updated: Oct 16, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

Area of Science:

  • Immunology
  • Endocrinology
  • Neurology

Background:

  • Multiple sclerosis (MS) and type 1 diabetes (T1D) are chronic autoimmune diseases stemming from immune system dysfunction.
  • Both conditions share genetic susceptibility and environmental triggers, leading to aberrant immune responses.
  • Understanding their similarities and differences is crucial for advancing autoimmune disease research.

Purpose of the Study:

  • To explore the commonalities and distinctions between MS and T1D.
  • To highlight the differing therapeutic strategies and typical age of onset for each disease.
  • To consider the potential impact of the SARS-CoV-2 pandemic on autoimmune conditions.

Main Methods:

  • Comparative analysis of existing literature on MS and T1D.
  • Review of immunological and clinical characteristics.
  • Examination of disease progression and treatment modalities.

Main Results:

  • Both MS and T1D are T-cell mediated autoimmune disorders with humoral immune involvement.
  • MS management primarily involves immunomodulation, while T1D treatment focuses on hormone replacement therapy.
  • T1D is typically diagnosed in younger individuals, whereas MS commonly affects young adults, impacting disease course and management.

Conclusions:

  • Despite shared autoimmune roots, MS and T1D exhibit distinct clinical and therapeutic profiles.
  • Age at diagnosis significantly influences disease progression and treatment strategies for MS and T1D.
  • The influence of factors like the SARS-CoV-2 pandemic on autoimmune disease prevalence and manifestation warrants further investigation.